Clinical Trials Browser

Phase 1 × Lymphoma, T-Cell × tazemetostat × Clear all

NCT05627245 2026-03-18

Testing the Safety of the Anti-cancer Drugs Tazemetostat and Belinostat in Patients With Lymphomas That Have Resisted Treatment

Phase 1 Active not recruiting

DermatologicLymphoid

Lymphoma, Follicular, Lymphoma, Non-Hodgkin, Lymphoma, B-Cell, Lymphoma, T-Cell, Lymphoma, T-Cell, Cutaneous

NCT05983965 2025-09-10

Study of Tazemetostat in Lymphoid Malignancies

Phase 1 Recruiting

LymphoidOther hematologic neoplasm

Leukemia, Lymphoma, Lymphoma, T-Cell